137 related articles for article (PubMed ID: 37990804)
1. Quantitative structure activity relationship (QSAR) modeling study of some novel thiazolidine 4-one derivatives as potent anti-tubercular agents.
Moulishankar A; Thirugnanasambandam S
J Recept Signal Transduct Res; 2023 Jun; 43(3):83-92. PubMed ID: 37990804
[TBL] [Abstract][Full Text] [Related]
2. 3D QSAR analysis of 2-(substituted aryl)-thiazolidine-4-carboxamides as potent antitubercular agents.
Nagasree KP; Kumar MM; Prasad YR; Sriram D; Yogeeswari P
Curr Comput Aided Drug Des; 2014; 10(3):274-81. PubMed ID: 25413596
[TBL] [Abstract][Full Text] [Related]
3. Impact of topological and electronic descriptors in the QSAR of pyrazine containing thiazolines and thiazolidinones as antitubercular and antibacterial agents.
Sivakumar PM; Geetha Babu SK; Doble M
Chem Biol Drug Des; 2008 May; 71(5):447-463. PubMed ID: 18384526
[TBL] [Abstract][Full Text] [Related]
4. A Structure-Activity Relationship Study of Naphthoquinone Derivatives as Antitubercular Agents Using Molecular Modeling Techniques.
Sharma MC
Interdiscip Sci; 2015 Dec; 7(4):346-56. PubMed ID: 26159131
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Study of 1D Descriptors Supported CoMFA and CoMSIA QSAR Models to Gain Novel Insights into 1,2,4-Triazoles Acting As Antitubercular Agents.
Ray R; Shenoy GG; Kumar TNVG
Curr Comput Aided Drug Des; 2021; 17(2):281-293. PubMed ID: 32116196
[TBL] [Abstract][Full Text] [Related]
6. ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines.
Saxena AK; Alam M
Curr Top Med Chem; 2020; 20(29):2723-2734. PubMed ID: 32885753
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Characterization, Antibacterial and Antioxidant Potency of NSubstituted- 2-Sulfanylidene-1,3-Thiazolidin-4-one Derivatives and QSAR Study.
Brahmbhatt H; Molnar M; Pavić V; Rastija V
Med Chem; 2019; 15(8):840-849. PubMed ID: 30520381
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents.
Kharkar PS; Desai B; Gaveria H; Varu B; Loriya R; Naliapara Y; Shah A; Kulkarni VM
J Med Chem; 2002 Oct; 45(22):4858-67. PubMed ID: 12383011
[TBL] [Abstract][Full Text] [Related]
9. Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies.
Ragno R; Marshall GR; Di Santo R; Costi R; Massa S; Rompei R; Artico M
Bioorg Med Chem; 2000 Jun; 8(6):1423-32. PubMed ID: 10896119
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
12. 2D-QSAR modeling and two-fold classification of 1,2,4-triazole derivatives for antitubercular potency against the dormant stage of Mycobacterium tuberculosis.
Aher RB; Sarkar D
Mol Divers; 2022 Apr; 26(2):1227-1242. PubMed ID: 34347229
[TBL] [Abstract][Full Text] [Related]
13. Antitubercular properties of thiazolidin-4-ones - A review.
Trotsko N
Eur J Med Chem; 2021 Apr; 215():113266. PubMed ID: 33588179
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
Ahmadinejad N; Shafiei F
Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
[TBL] [Abstract][Full Text] [Related]
15. In silico Studies, Synthesis and Antitubercular Activity of Some Novel Quinoline - Azitidinone Derivatives.
Chitre TS; Asgaonkar KD; Vikhe AB; Patil SM; Garud DR; Khedkar VM; Sarkar D; Nawale LU; Yeware A
Curr Comput Aided Drug Des; 2021; 17(1):134-143. PubMed ID: 31995017
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents.
Hevener KE; Ball DM; Buolamwini JK; Lee RE
Bioorg Med Chem; 2008 Sep; 16(17):8042-53. PubMed ID: 18701298
[TBL] [Abstract][Full Text] [Related]
17. 2D QSAR Analysis of Substituted Quinoxalines for their Antitubercular and Antileptospiral Activities.
Natarajan R; Puratchikody A; Muralidharan V; Doble M; Subramani A
Curr Comput Aided Drug Des; 2019; 15(2):182-192. PubMed ID: 30317999
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides.
Virsodia V; Pissurlenkar RR; Manvar D; Dholakia C; Adlakha P; Shah A; Coutinho EC
Eur J Med Chem; 2008 Oct; 43(10):2103-15. PubMed ID: 17950956
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines.
Manvar AT; Pissurlenkar RR; Virsodia VR; Upadhyay KD; Manvar DR; Mishra AK; Acharya HD; Parecha AR; Dholakia CD; Shah AK; Coutinho EC
Mol Divers; 2010 May; 14(2):285-305. PubMed ID: 19554465
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial activity evaluation, time-kill kinetic and 3D-QSAR study of C-(3-aminomethyl-cyclohexyl)-methylamine derivatives.
Kumar D; Raj KK; Bailey M; Alling T; Parish T; Rawat DS
Bioorg Med Chem Lett; 2013 Mar; 23(5):1365-9. PubMed ID: 23357633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
